Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Rapid design and development of CRISPR-Cas13a targeting SARS-CoV-2 spike protein

28 Oct 2020

Abstract excerpt

: This study provides a rapid design pipeline for a CRISPR-Cas13a-based antiviral tool against SARS-CoV-2. Moreover, it offers a novel approach for anti-virus study even if the precise structures of viral proteins are indeterminate.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CRISPR and Genetic Engineering
Share to Mosquito-borne diseases and control
Share to SARS-CoV-2 and COVID-19 Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33391497
DOI: 10.7150/thno.51479

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Rapid design and development of CRISPR-Cas13a targeting SARS-CoV-2 spike proteinPMID 33391497Read ↗

The CRISPR/Cas13 system edits viral spike and nucleocapsid RNA to resist SARS-CoV-2 infectionSemantic proximity Read ↗

Double-Barreled CRISPR Technology as a Novel Treatment Strategy For COVID-19Semantic proximity Read ↗

CRISPR–Cas12-based detection of SARS-CoV-2Semantic proximity Read ↗

CRISPR-cas13 enzymology rapidly detects SARS-CoV-2 fragments in a clinical settingSemantic proximity Read ↗

Reprogrammed CRISPR-Cas13b suppresses SARS-CoV-2 replication and circumvents its mutational escape through mismatch tolerance.Semantic proximity Read ↗

Development of CRISPR as an Antiviral Strategy to Combat SARS-CoV-2 and InfluenzaSemantic proximity Read ↗

Reprogrammed CRISPR-Cas13b suppresses SARS-CoV-2 replication and circumvents its mutational escape through mismatch toleranceSemantic proximity Read ↗

CRISPR-Cas13a cascade-based viral RNA assay for detecting SARS-CoV-2 and its mutations in clinical samplesSemantic proximity Read ↗

Engineering CRISPR/Cas13 System against RNA Viruses: From Diagnostics to TherapeuticsSemantic proximity Read ↗

Exploring the future of SARS-CoV-2 treatment after the first two years of the pandemic: A comparative study of alternative therapeuticsSemantic proximity Read ↗

CRISPR/Cas13-Based Anti-RNA Viral ApproachesSemantic proximity Read ↗

CRISPR/Cas13-Based Anti-RNA Viral ApproachesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.